Clinical trial
Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales: a Comparative Retrospective Cohort Study (OPTIC-19)
NCT04838106 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales: a Comparative Retrospective Cohort Study (OPTIC-19)
- Lead sponsor
- University of Oxford
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2020
- Completion date
- February 28, 2025
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, critical illness, deep vein thrombosis, heart failure, myocardial infarction, pulmonary embolism, renal failure, stroke